Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 175 publications
Erratum: Safety, Tolerability, and Antitumor Activity of Zipalertinib Among Patients With Non-Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 20 Insertions.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 14, 2026
Innovate or Be Left Behind: A Path to Prospective External Control Arms for Accelerated Oncology Drug Development.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 05, 2026
Tiragolumab Plus Atezolizumab and Chemotherapy for Advanced Nonsquamous Non-Small Cell Lung Cancer: The Phase 3 SKYSCRAPER-06 Randomized Clinical Trial.
Journal: JAMA oncology
Published: April 30, 2026
AdvanTIG-302: Phase 3 Study of Ociperlimab (Anti-TIGIT) + Tislelizumab (Anti-PD-1) Versus Pembrolizumab in Untreated, Locally Advanced, Unresectable, or Metastatic Non-Small Cell Lung Cancer With PD-L1 ≥50.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: February 22, 2026
Gotistobart or docetaxel in metastatic squamous non-small cell lung cancer: stage 1 of the randomized phase 3 PRESERVE-003 trial.
Journal: Nature medicine
Published: January 29, 2026
Non-small cell lung cancer molecular subtypes and vulnerability to immunotherapy treatment combinations.
Journal: Nature communications
Published: June 24, 2025
Digital Versus Manual PD-L1 Scoring in Advanced NSCLC From the IMpower110 and IMpower150 Trials.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: April 30, 2025
Prevalence and molecular correlates of acquired EGFR resistance mutations in non-small cell lung cancer (NSCLC).
Journal: Expert review of anticancer therapy
Published: April 16, 2025
Phase 2 Study of Zilovertamab Vedotin in Participants with Metastatic Solid Tumors.
Journal: Cancer research communications
Published: February 12, 2025
Concurrent and Consolidative Carboplatin Plus Nab-Paclitaxel or Paclitaxel in Locally Advanced NSCLC: A Multicenter, Randomized Clinical Trial.
Journal: International journal of radiation oncology, biology, physics
Published: October 21, 2024
Correlation of safety and efficacy of atezolizumab therapy across indications.
Journal: Journal for immunotherapy of cancer
Published: October 18, 2024
Last Updated: 09/26/2026